» Articles » PMID: 3490919

Isolation and Characterization of Antigen-Ia Complexes Involved in T Cell Recognition

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1986 Dec 26
PMID 3490919
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

Using equilibrium dialysis, it has been previously demonstrated that immunogenic peptides bind specifically to the Ia molecules serving as restriction elements in the immune response to these antigens. Using gel filtration to study the formation of ovalbumin (OVA) peptide-I-Ad complexes, it is herein demonstrated that the complexes, once formed, are very stable (kd approximately equal to 3 X 10(-6) s-1), but the rate of complex formation is very slow (ka approximately 1 M-1 s-1 explaining the overall low equilibrium constant of approximately 2 X 10(-6) M. Treating the complexes with glutaraldehyde revealed that the ovalbumin peptide was cross-linked solely to the alpha chain of I-Ad. Planar membranes containing I-Ad-OVA complexes stimulated a T cell response with 2 X 10(4) less antigen than required when uncomplexed antigen was used, thus demonstrating the biologic importance of these complexes in antigen recognition.

Citing Articles

Relationship between protein conformational stability and its immunogenicity when administering antigens to mice using adjuvants-Analysis employed the CH2 domain in human antibodies.

Oyama K, Ueda T PLoS One. 2024; 19(7):e0307320.

PMID: 39038003 PMC: 11262634. DOI: 10.1371/journal.pone.0307320.


Immunogenicity Assessment of Therapeutic Peptides.

Li W, Wei J, Jiang Q, Zhou Y, Yan X, Xiang C Curr Med Chem. 2024; 31(26):4100-4110.

PMID: 38275064 DOI: 10.2174/0109298673264899231206093930.


Immunoinformatics: Predicting Peptide-MHC Binding.

Nielsen M, Andreatta M, Peters B, Buus S Annu Rev Biomed Data Sci. 2023; 3:191-215.

PMID: 37427310 PMC: 10328453. DOI: 10.1146/annurev-biodatasci-021920-100259.


TransMHCII: a novel MHC-II binding prediction model built using a protein language model and an image classifier.

Yu X, Negron C, Huang L, Veldman G Antib Ther. 2023; 6(2):137-146.

PMID: 37342671 PMC: 10278228. DOI: 10.1093/abt/tbad011.


Antigen-specific and cross-reactive T cells in protection and disease.

Jiang N, Malone M, Chizari S Immunol Rev. 2023; 316(1):120-135.

PMID: 37209375 PMC: 10524458. DOI: 10.1111/imr.13217.